Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Journal of Cancer Research and Clinical Oncology|December 11, 2008
Sodium valproate, a histone deacetylase inhibitor, decreases the secretion of soluble Fas by human osteosarcoma cells and increases their sensitivity to Fas-mediated cell deathKoji Yamanegi, Junko Yamane, Masaki Hata, et al.
Toxicology Letters|May 5, 2012
Effects of methylmercury exposure on neuronal differentiation of mouse and human embryonic stem cellsXiaoming He, Satoshi Imanishi, Hideko Sone, et al.
Oncology Reports|August 28, 2012
Downregulation of matrix metalloproteinase-9 mRNA by valproic acid plays a role in inhibiting the shedding of MHC class I-related molecules A and B on the surface of human osteosarcoma cellsKoji Yamanegi, Junko Yamane, Kenta Kobayashi, et al.
BMC Bioinformatics|June 15, 2023
eSPRESSO: topological clustering of single-cell transcriptomics data to reveal informative genes for spatio-temporal architectures of cellsTomoya Mori, Toshiro Takase, Kuan-Chun Lan, et al.
International Journal of Oncology|May 12, 2012
Valproic acid cooperates with hydralazine to augment the susceptibility of human osteosarcoma cells to Fas- and NK cell-mediated cell deathKoji Yamanegi, Junko Yamane, Kenta Kobayashi, et al.
Scientific Reports|February 7, 2025
Mechanistic elucidation of human pancreatic acinar development using single-cell transcriptome analysis on a human iPSC differentiation modelAtsushi Mima, Azuma Kimura, Ryo Ito, et al.
Oncology Reports|November 3, 2010
Sodium valproate, a histone deacetylase inhibitor, augments the expression of cell-surface NKG2D ligands, MICA/B, without increasing their soluble forms to enhance susceptibility of human osteosarcoma cells to NK cell-mediated cytotoxicityKoji Yamanegi, Junko Yamane, Kenta Kobayashi, et al.
Cancer Science|February 20, 2016
SERPINI1 regulates epithelial-mesenchymal transition in an orthotopic implantation model of colorectal cancerYasufumi Matsuda, Koh Miura, Junko Yamane, et al.
Biomaterials|April 8, 2022
Human iPS cell-derived cartilaginous tissue spatially and functionally replaces nucleus pulposusTakashi Kamatani, Hiroki Hagizawa, Seido Yarimitsu, et al.
Iscience|June 27, 2022
StemPanTox: A fast and wide-target drug assessment system for tailor-made safety evaluations using personalized iPS cellsJunko Yamane, Takumi Wada, Hironori Otsuki, et al.
Pageof 2